Public health and budget impacts of switching from a trivalent to a quadrivalent inactivated influenza vaccine in Paraguay

References

• Zambon MC. Epidemiology and pathogenesis of influenza. J Antimicrob Chemother. 1999;44(Suppl B):3–9. doi:10.1093/jac/44.suppl_2.3.
   PubMedGoogle Scholar
• Arbeitskreis blut, untergruppe «Bewertung Blutassoziierter Krankheitserreger» “Influenza Virus” Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie. 2009;36(1):32–39.
   Google Scholar
• Paget J, Spreeuwenberg P, Charu V, Taylor RJ, Iuliano AD, Bresee J, Simonsen L, Viboud C, Global Seasonal Influenza-associated Mortality Collaborator N, Teams* GLC. Global mortality associated with seasonal influenza epidemics: New burden estimates and predictors from the GLaMOR project. J Glob Health. 2019;9:020421. doi:10.7189/jogh.09.020421.
   PubMed Web of Science ®Google Scholar
• Bataglia S, Von Horoch M, Cabello A, Penayo E, Vázquez C. Carga de Influenza asociadas a hospitalizaciones y muertes en Paraguay, 2011-2015. Revista Paraguaya de Epidemiologia. 2017;4:25–33.
   Google Scholar
• WHO SAGE seasonal influenza vaccination recommendations during the COVID-19 pandemic; 2020.
   Google Scholar
• Mertz D, Kim TH, Johnstone J, Lam PP, Science M, Kuster SP, Fadel SA, Tran D, Fernandez E, Bhatnagar N, et al. Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis. BMJ. 2013;347:f5061. doi:10.1136/bmj.f5061.
   PubMed Web of Science ®Google Scholar
• Ministerio de Salud Publica y Bienestar Social. Programa Ampliado de Inmunizaciones. Influenza. Accessed 25 April 2022. https://pai.mspbs.gov.py/influenza/
   Google Scholar
• Palekar R, Rodriguez A, Avila C, Barrera G, Barrera M, Brenes H, Bruno A, El Omeiri N, Fasce R, Ferreira de Almeida W, et al. Patterns of influenza B circulation in Latin America and the Caribbean, 2010-2017. PloS One. 2019;14:e0219595. doi:10.1371/journal.pone.0219595.
   PubMed Web of Science ®Google Scholar
• Reed C, Meltzer MI, Finelli L, Fiore A. Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine. Vaccine. 2012;30:1993–98. doi:10.1016/j.vaccine.2011.12.098.
   PubMed Web of Science ®Google Scholar
• Ruiz-Palacios GM, Beigel JH, Guerrero ML, Bellier L, Tamayo R, Cervantes P, Alvarez FP, Galindo-Fraga A, Aguilar-Ituarte F, Lopez JG. Public health and economic impact of switching from a trivalent to a quadrivalent inactivated influenza vaccine in Mexico. Hum Vaccin Immunother. 2020;16:827–35. doi:10.1080/21645515.2019.1678997.
   PubMed Web of Science ®Google Scholar
• Uhart M, Bricout H, Clay E, Largeron N. Public health and economic impact of seasonal influenza vaccination with quadrivalent influenza vaccines compared to trivalent influenza vaccines in Europe. Human Vaccines Immunother. 2016;12:2259–68. doi:10.1080/21645515.2016.1180490.
   PubMed Web of Science ®Google Scholar
• Jamotte A, Chong CF, Manton A, Macabeo B, Toumi M. Impact of quadrivalent influenza vaccine on public health and influenza-related costs in Australia. BMC Public Health. 2016;16(1):630. doi:10.1186/s12889-016-3297-1.
   Google Scholar
• Instituto Nacional de Estadística. Paraguay, Proyección de la población por sexo y edad, según distrito, 2000-2025. Revisión 2015”. Available at https://www.ine.gov.py/Publicaciones/Biblioteca/documento/7132_Proyeccion%20Distrital.pdf
   Google Scholar
• Clark A, Jit M, Warren-Gash C, Guthrie B, Wang HHX, Mercer SW, Sanderson C, McKee M, Troeger C, Ong KL, et al. Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study. Lancet Global Health. 2020;8(8):e1003–e17. doi:10.1016/S2214-109X(20)30264-3.
   PubMed Web of Science ®Google Scholar
• Piroth L, Cottenet J, Mariet A-S, Bonniaud P, Blot M, Tubert-Bitter P, Quantin C. Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study. Lancet Resp Med. 2021;9(3):251–59. doi:10.1016/S2213-2600(20)30527-0.
   Google Scholar
• Jefferson T, Di Pietrantonj C Rivetti A, Bawazeer GA, Al-Ansary LA, Ferroni E. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev. 2014;3:CD004876. PMID: 20614424. doi: 10.1002/14651858.CD001269.pub4.
   Google Scholar
• Clements KM, Meier G, McGarry LJ, Pruttivarasin N, Misurski DA. Cost-Effectiveness analysis of universal influenza vaccination with quadrivalent inactivated vaccine in the United States. Hum Vaccin Immunother. 2014;10:1171–80. doi:10.4161/hv.28221.
   PubMed Web of Science ®Google Scholar
• Jefferson T, Rivetti A, Harnden A, Di Pietrantonj C, Demicheli V. Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev. 20012;8:CD004879. PMID: 18425905. doi:10.1002/14651858.CD004879.pub3.
   Google Scholar
• Osterholm MT, Kelley NS, Sommer A, Belongia BA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet. 2011;12:36–44. doi:10.1016/S1473-3099(11)70295-X.
   Web of Science ®Google Scholar
• Tricco AC, Chit A, Soobiah C, Hallett D, Meier G, Chen MH, Tashkandi M, Bauch CT, Loeb M. Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis. BMC Med. 2013;11. doi:10.1186/1741-7015-11-153.
   PubMed Web of Science ®Google Scholar
• Vazquez C, Ortega MJ, Villalba S, Horoch MV, Gamarra ML, Torales J, Gomez A, Chamorro G, Caello A. Detection of influenza b lineages from 2013 to 2015 at the sentinel surveillance of influenza in paraguay. Annual Meeting of the European Society for Paediatric Infectious Diseases, Brighton, UK; 2016:ESP16–1106.
   Google Scholar
• Boletines epidemiologico Semanal (2010-2017). Dirección General de Vigilencia de la Salud.
   Google Scholar
• Molinari NA, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Wortley PM, Weintraub E, Bridges CB. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine. 2007;25(27):5086–96. doi:10.1016/j.vaccine.2007.03.046.
   PubMed Web of Science ®Google Scholar
• Egresos Hospitalarios por años y Grupos de Edad, Según Regiones Sanitarias, Distritos y Establecimientos de Salud Del MSPyBS. 2019.
   Google Scholar
• Bayer C, Remschmidt C, An der Heiden M, Tolksdorf K, Herzhoff M, Kaersten S, Buda S, Haas W, Buchholz U. Internet-Based syndromic monitoring of acute respiratory illness in the general population of Germany, weeks 35/2011 to 34/2012. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin. Jan 2014;19(4). PMID: 24507468. doi:10.2807/1560-7917.es2014.19.4.20684.
   Google Scholar
• Reed C, Chaves SS, Daily Kirley P, Emerson R, Aragon D, Hancock EB, Butler L, Baumbach J, Hollick G, Bennett NM, et al. Estimating influenza disease burden from population-based surveillance data in the United States. PloS One. 2015;10(3):e0118369. doi:10.1371/journal.pone.0118369.
   PubMed Web of Science ®Google Scholar
• Jefferson T, Rivetti A, Di Pietrantonj C, Demicheli V, Ferroni E . Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev. Feb 2018;1(2): CD004879. PMID: 22895945.
   Google Scholar
• Demicheli V, Jefferson T, Al-Ansary LA, Ferroni EAR, Di Pietrantonj C . Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev. Feb 2018;1(2): CD001269. PMID: 24623315. doi:10.1002/14651858.CD001269.pub5.
   Google Scholar
• Jefferson T, Di Pietrantonj C, Rivetti A, Bawazeer GA, Al-Ansary LA, Ferroni E. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev. 2014;3:CD001269. PMID: 20614424.
   PubMedGoogle Scholar
• Flunet. Influenza laboratory surveillance data. World health organization, 2012-2017.
   Google Scholar
• Development of inflation rates in Paraguay. WorldDatainfo; 2020. Available at https://www.worlddata.info/america/paraguay/inflation-rates.php
   Google Scholar
• Ministerio de Hacienda. Sistema Integrado de Contabilidad. Reportes de presupuesto y ejecución presupuestaria.
   Google Scholar
• Kieninger Martha Peña. et al.Cost-Effectiveness analysis of pneumococcal conjugate vaccine introduction in Paraguay. Vaccine. 2015;33(Suppl 1):A143–53.
   PubMedGoogle Scholar
• Panamerican health Organization. Revolving Fund Vaccine Prices 2018. Available at https://www.paho.org/en/documents/revolving-fund-vaccine-prices-2018
   Google Scholar
• Paraguay - Encuesta Permanente de Hogares Continua, I, II, III y IV Trimestres de 2018. In: La Dirección General de Estadística EyC-D, ed.; 2018.
   Google Scholar
• Tinoco YO, Azziz-Baumgartner E, Uyeki TM, Rázuri HR, Kasper MR, Romero C, Silva ME, Simons MP, Soto GM, Widdowson MA, et al. Burden of influenza in 4 ecologically distinct regions of Peru: household active surveillance of a community Cohort, 2009-2015. Clin Infect Dis. 2017;65:1532–41. doi:10.1093/cid/cix565.
   PubMed Web of Science ®Google Scholar
• Flunet. Influenza laboratory surveillance information 2013 to 2018.
   Google Scholar
• García A, Aristegui J, Moreno D, Redondo E, Jimeno I, Cenoz MG, López Trigo JA. Documento de reflexión sobre la vacunación antigripal tetravalente. Asociación Españo la de Vacunología. 2019. https://vacunasaep.org/sites/vacunasaep.org/files/act_y_refl_vac_gripe_tetra._vfinal_2019.pdf
   Google Scholar
• Dos Santos G, Neumeier E, Bekkat-Berkani R. Influenza: can we cope better with the unpredictable? Hum Vaccin Immunother. 2016;12:699–708. doi:10.1080/21645515.2015.1086047.
   PubMed Web of Science ®Google Scholar
• Barr IG, Jelley LL. The coming era of quadrivalent human influenza vaccines: who will benefit? Drugs. 2012;72(17):2177–85. doi:10.2165/11641110-000000000-00000.
   Google Scholar
• Dolin R. The quadrivalent approach to influenza vaccination. J Infect Dis. 2013;208(4):539–40. doi:10.1093/infdis/jit264.
   PubMed Web of Science ®Google Scholar
• Belshe RB. The need for quadrivalent vaccine against seasonal influenza. Vaccine. 2010;28(Suppl 4):D45–53. doi:10.1016/j.vaccine.2010.08.028.
   PubMed Web of Science ®Google Scholar
• Coleman BL, Fadel SA, Fitzpatrick T, Thomas SM. Risk factors for serious outcomes associated with influenza illness in high- versus low- and middle-income countries: systematic literature review and meta-analysis. Influenza Other Respi Viruses. 2018;12:22–29. doi:10.1111/irv.12504.
   PubMed Web of Science ®Google Scholar